About NIPD Genomics
NIPD Genomics is a Healthcare company based in Nicosia (Cyprus) founded in 2015, and was acquired by Medicover in December 2021. Genetic tests for diagnosing diseases are provided by NIPD Genomics. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics.
Company details
NIPD Genomics was founded in 2015 and is headquartered in Nicosia, Cyprus. Operations focus on the genomics sector, where genetic tests are developed for diagnosing hereditary conditions. The flagship product, Veracity, employs next-generation sequencing and bioinformatics to examine cell-free fetal DNA from maternal blood samples, targeting common genetic disorders. Additional test panels are offered for cancer screening and reproductive health assessments.
Investors in NIPD Genomics
NIPD Genomics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Medicover.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Multispeciality hospitals are operated as a chain in healthcare. | 1995 | medicover.com | Warsaw, Poland |
Investor details for NIPD Genomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of NIPD Genomics
2 dated milestones of NIPD Genomics across 6 years, from founding to its latest funding, stage changes and deals.
- Founded NIPD Genomics is founded.
- Exit Acquired by Medicover.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nipd Genomics
Complete news archive for NIPD Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NIPD Genomics
NIPD Genomics was founded in 2015.
NIPD Genomics is headquartered in Nicosia, Cyprus.
NIPD Genomics was founded in 2015 and is headquartered in Nicosia, Cyprus. Operations focus on the genomics sector, where genetic tests are developed for diagnosing hereditary conditions. The flagship product, Veracity, employs next-generation sequencing and bioinformatics to examine cell-free fetal DNA from maternal blood samples, targeting common genetic disorders. Additional test panels are offered for cancer screening and reproductive health assessments.
NIPD Genomics has 1 investor. Key investors include Medicover.
Yes. NIPD Genomics was acquired by Medicover in December 2021.